Covidien CEO buys and sells 50,000 shares

Covidien chief executive José Almeida sold 50,000 shares in his company last Friday, worth $3.6 million at the time he sold them, the Ireland-based medical device maker has disclosed. The insider sale was part of a previously disclosed trading plan. On the same day, Almeida acquired 50,000 with a stock option priced at $39.32 per share. Shares in Covidien ($COV) are trading around $72 this morning, about the same price as their Friday close. Almeida still holds 51,166 shares in the company, according to the SEC filing.

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.